- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rosiglitazone insulin sensitizing agent
Total 2891 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNetherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJordan
-
Novo Nordisk A/SCompletedHealthy | DiabetesSouth Africa
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTunisia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedAlzheimer's DiseaseGermany
-
Laval UniversityGlaxoSmithKlineCompletedDiabetes | Coronary Artery Bypass GraftingSpain, Canada
-
University of WashingtonGlaxoSmithKline; Seattle Institute for Biomedical and Clinical ResearchCompleted
-
St. Paul Heart ClinicGlaxoSmithKlineCompletedType 2 Diabetes MellitusUnited States
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompleted
-
WockhardtCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedObservational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)Diabetes Mellitus, Type 2 | DiabetesAustria
-
SanofiTerminatedAMICanada, Brazil, United States, Argentina, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, United Kingdom, Spain, Denmark, France, Netherlands, Austria, Hungary, Russian Federation, Germany, Turkey, Italy, Bulgaria, Romania, Belgium, Switzerland, Slovenia, Czech Republic
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Delivery SystemsIndonesia
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
National Taiwan University HospitalCompletedDiabetes Mellitus Non Insulin Dependent Oral Agent TherapyTaiwan
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Hyperinsulinemia | LipodystrophyUnited States
-
National Cheng-Kung University HospitalCompletedCoronary Artery Disease | Insulin Resistance | Glucose Intolerance | Prediabetes
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesHungary
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovenia
-
Baskent UniversityCompletedDiabetes Mellitus, Type 2Turkey
-
SanofiTerminated
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand, Mexico, Brazil
-
Baskent UniversityCompletedDiabetes Mellitus, Type 2Turkey
-
GlaxoSmithKlineTerminatedAlzheimer's DiseaseUnited Kingdom
-
University of LeipzigCompletedImpaired Glucose Tolerance
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFinland
-
New York Medical CollegeAlbert Einstein College of Medicine; University of TennesseeCompletedObesity | Insulin Resistance | HyperinsulinemiaUnited States
-
National Cancer Institute (NCI)Completed
-
National Center for Research Resources (NCRR)The Campbell FoundationCompletedHIV Infections | Insulin ResistanceUnited States
-
Vanderbilt UniversityCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
University Medical Centre LjubljanaCompletedInsulin ResistanceSlovenia
-
WockhardtCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesArgentina, Brazil
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFormer Serbia and Montenegro